Moreover, CDH19 might serve as a new target of tumorigenesis and drug development for glioblastoma stem-like cells (GSC) and can be considered an independent prognostic biomarker of lung adenocarcinoma (LUAD) and breast cancer (BC) [36, 40, 41]. This evidence concerns the gene CDH19 and lung adenocarcinoma.